Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.